Semler Scientific (SMLR) stock price, revenue, and financials

Semler Scientific market cap is $753.2 m, and annual revenue was $38.6 m in FY 2020

$753.2 M

SMLR Mkt cap, 22-Sept-2021

$13.2 M

Semler Scientific Revenue Q1, 2021
Semler Scientific Gross profit (Q1, 2021)11.6 M
Semler Scientific Gross profit margin (Q1, 2021), %88%
Semler Scientific Net income (Q1, 2021)4.9 M
Semler Scientific EBIT (Q1, 2021)6 M
Semler Scientific Cash, 31-Mar-202126.5 M
Semler Scientific EV727.1 M
Get notified regarding key financial metrics and revenue changes at Semler ScientificLearn more
Banner background

Semler Scientific Revenue

Semler Scientific revenue was $38.6 m in FY, 2020

Embed Graph

Semler Scientific Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

3.6m7.0m7.4m12.5m21.5m32.8m38.6m

Cost of goods sold

692.0k2.8m1.9m2.6m2.1m3.7m3.4m

Gross profit

2.9m4.2m5.6m9.9m19.4m29.1m35.2m

Gross profit Margin, %

81%59%75%79%90%89%91%

Sales and marketing expense

3.7m6.3m3.8m5.1m7.2m9.0m9.9m

R&D expense

1.1m1.4m866.0k1.8m

General and administrative expense

2.4m4.9m3.0m3.8m4.2m7.0m6.4m

Operating expense total

7.3m12.6m7.7m10.8m14.1m18.4m19.3m

EBIT

(4.3m)(8.4m)(2.2m)(853.0k)5.3m10.7m16.0m

EBIT margin, %

(119%)(120%)(29%)(7%)25%33%41%

Interest expense

174.0k82.0k395.0k657.0k302.0k2.0k19.0k

Pre tax profit

5.0m10.7m16.5m

Income tax expense

9.0k6.0k10.0k15.0k26.0k(4.4m)2.5m

Net Income

(4.5m)(8.5m)(2.6m)(1.5m)5.0m15.1m14.0m

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

837.0k846.0k897.0k1.2m1.3m1.6m1.5m1.6m2.0m2.1m2.6m3.6m4.5m5.5m5.6m6.8m8.0m8.9m9.4m6.4m10.7m13.2m

Cost of goods sold

155.0k172.0k178.0k220.0k244.0k385.0k417.0k533.0k398.0k540.0k592.0k724.0k704.0k489.0k587.0k569.0k591.0k974.0k850.0k700.0k820.0k1.6m

Gross profit

682.0k674.0k719.0k982.0k1.1m1.2m1.1m1.1m1.6m1.5m2.0m2.9m3.8m5.0m5.0m6.2m7.4m7.9m8.6m5.7m9.9m11.6m

Gross profit Margin, %

81%80%80%82%81%75%72%67%80%74%77%80%84%91%89%92%93%89%91%89%92%88%

Sales and marketing expense

746.0k728.0k1.0m1.2m1.3m1.3m974.0k1.0m950.0k988.0k1.2m1.4m1.7m1.8m1.8m2.1m2.2m2.3m2.7m2.5m2.1m2.8m

R&D expense

229.0k416.0k262.0k309.0k406.0k268.0k270.0k182.0k183.0k474.0k432.0k367.0k

General and administrative expense

497.0k539.0k784.0k793.0k662.0k1.1m772.0k763.0k706.0k838.0k902.0k1.0m874.0k1.0m1.0m1.4m1.6m1.9m1.6m1.5m1.6m2.1m

Operating expense total

1.5m1.7m2.1m2.3m2.4m2.7m2.0m2.0m1.8m1.8m2.5m2.8m2.9m3.5m3.4m4.3m4.7m4.8m5.1m4.7m4.4m5.6m

EBIT

(790.0k)(1.0m)(1.4m)(1.3m)(1.3m)(1.6m)(932.0k)(870.0k)(255.0k)(750.0k)(554.0k)76.0k813.0k1.5m1.5m1.9m2.7m3.1m3.5m960.0k5.6m6.0m

EBIT margin, %

(94%)(119%)(152%)(112%)(101%)(99%)(62%)(53%)(13%)(36%)(21%)2%18%28%28%27%34%35%37%15%52%46%

Interest expense

27.0k23.0k99.0k24.0k28.0k28.0k116.0k296.0k117.0k107.0k82.0k78.0k1.0k3.0k2.0k1.0k2.0k3.0k

Pre tax profit

(1.5m)2.7m3.1m3.5m990.0k5.6m6.0m

Income tax expense

77.0k(4.7m)777.0k(85.0k)729.0k1.1m

Net Income

(817.0k)(1.0m)(1.5m)(1.4m)(1.3m)(1.6m)(1.0m)(966.0k)(362.0k)(871.0k)(850.0k)(41.0k)706.0k1.5m1.5m1.9m2.6m7.8m2.7m1.1m4.9m4.9m

Semler Scientific Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

4.2m405.0k622.0k1.5m3.3m7.7m22.1m

Accounts Receivable

355.0k1.3m7.9m1.3m2.8m3.5m2.8m

Prepaid Expenses

135.0k69.0k111.0k153.0k216.0k1.4m

Current Assets

6.7m1.8m1.6m2.9m6.2m11.4m26.3m

PP&E

9.0k497.0k590.0k193.0k223.0k249.0k261.0k

Total Assets

7.5m3.1m3.1m4.2m7.7m18.3m34.6m

Accounts Payable

89.0k839.0k450.0k488.0k280.0k338.0k677.0k

Short-term debt

75.0k

Current Liabilities

4.1m4.1m3.2m5.1m3.5m5.2m4.5m

Long-term debt

1.7m332.0k

Non-Current Liabilities

43.0k2.8m1.7m11.0k7.0k332.0k

Total Debt

1.7m407.0k

Common Stock

5.0k5.0k6.0k6.0k7.0k7.0k

Additional Paid-in Capital

17.3m21.3m22.0m23.8m25.6m19.4m22.1m

Retained Earnings

(13.9m)(22.4m)(24.9m)(26.4m)(21.4m)(6.3m)7.7m

Total Equity

3.4m(1.1m)(2.9m)(2.6m)4.2m13.1m29.8m

Debt to Equity Ratio

-0.6 x

Debt to Assets Ratio

0.4 x

Financial Leverage

2.2 x-2.9 x-1.1 x-1.6 x1.8 x1.4 x1.2 x

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

7.6m6.6m6.0m3.1m2.3m1.9m1.4m1.0m517.0k496.0k578.0k419.0k2.0m3.1m4.5m4.2m8.5m11.2m13.6m16.8m26.5m

Accounts Receivable

157.0k127.0k311.0k356.0k262.0k439.0k599.0k607.0k897.0k885.0k1.5m2.4m1.9m2.5m2.5m3.5m3.3m1.6m982.0k3.5m4.4m

Prepaid Expenses

223.0k169.0k168.0k144.0k125.0k90.0k132.0k126.0k134.0k100.0k158.0k204.0k216.0k171.0k225.0k213.0k274.0k688.0k639.0k1.5m1.8m

Inventories

639.0k

Current Assets

8.0m6.9m6.5m5.7m4.8m2.5m2.2m1.8m1.5m1.5m2.2m3.0m4.1m5.7m7.3m7.9m12.1m13.5m15.3m21.8m33.3m

PP&E

5.0k7.0k6.0k26.0k48.0k188.0k473.0k452.0k544.0k507.0k470.0k203.0k247.0k245.0k220.0k215.0k220.0k310.0k287.0k258.0k351.0k

Total Assets

8.7m7.7m7.2m6.4m5.7m3.5m3.4m3.1m3.0m3.2m3.9m4.3m5.3m7.0m9.1m9.8m18.9m19.6m21.4m28.0m40.6m

Accounts Payable

139.0k161.0k217.0k89.0k116.0k61.0k390.0k430.0k281.0k546.0k647.0k341.0k185.0k251.0k257.0k405.0k669.0k377.0k207.0k336.0k470.0k

Short-term debt

47.0k45.0k1.0m1.1m77.0k

Current Liabilities

1.7m1.6m2.6m3.8m4.0m2.9m3.1m3.3m3.3m5.0m5.6m5.8m5.1m4.7m2.9m3.6m4.7m3.8m4.4m5.7m5.1m

Long-term debt

53.0k44.0k1.8m1.9m16.0k6.0k419.0k305.0k

Non-Current Liabilities

136.0k112.0k3.0k48.0k2.0m2.3m2.4m1.8m1.9m29.0k18.0k12.0k10.0k9.0k8.0k345.0k305.0k

Total Debt

100.0k89.0k2.8m2.9m16.0k6.0k419.0k382.0k

Common Stock

5.0k5.0k5.0k5.0k5.0k5.0k5.0k5.0k5.0k5.0k5.0k6.0k6.0k6.0k6.0k6.0k7.0k7.0k7.0k7.0k7.0k

Additional Paid-in Capital

17.1m17.1m17.3m17.8m18.3m18.7m21.7m21.8m21.9m23.0m23.1m24.2m24.5m25.1m25.7m23.2m23.3m19.5m19.6m19.8m22.7m

Retained Earnings

(10.2m)(11.2m)(12.7m)(15.2m)(16.6m)(18.2m)(23.4m)(24.3m)(24.7m)(26.6m)(26.7m)(25.7m)(24.3m)(22.8m)(19.6m)(16.9m)(9.2m)(3.7m)(2.6m)2.3m12.6m

Total Equity

6.9m5.9m4.6m2.6m1.7m531.0k(1.7m)(2.5m)(2.8m)(3.6m)(3.6m)(1.5m)216.0k2.3m6.2m6.2m14.1m15.8m17.0m22.1m35.3m

Debt to Equity Ratio

0 x0 x-0.8 x-0.8 x0 x0 x

Debt to Assets Ratio

0 x0 x0.9 x0.8 x0 x0 x

Financial Leverage

1.3 x1.3 x1.6 x2.5 x3.3 x6.6 x-2.1 x-1.2 x-1.1 x-0.9 x-1.1 x-2.8 x24.6 x3 x1.5 x1.6 x1.3 x1.2 x1.3 x1.3 x1.2 x

Semler Scientific Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(4.5m)(8.5m)(2.6m)(1.5m)5.0m15.1m14.0m

Depreciation and Amortization

196.0k315.0k452.0k559.0k503.0k632.0k576.0k

Accounts Receivable

(255.0k)(1.2m)293.0k(479.0k)(1.5m)(734.0k)623.0k

Accounts Payable

(167.0k)750.0k(389.0k)38.0k(208.0k)58.0k339.0k

Cash From Operating Activities

(3.8m)(4.1m)(1.8m)621.0k4.7m12.7m15.4m

Purchases of PP&E

(9.0k)(532.0k)(223.0k)(47.0k)(138.0k)(174.0k)(149.0k)

Cash From Investing Activities

(2.5m)996.0k(814.0k)(968.0k)(843.0k)(1.7m)(1.3m)

Long-term Borrowings

(270.0k)(2.0m)(43.0k)(144.0k)(2.9m)

Cash From Financing Activities

9.8m(612.0k)2.8m1.2m(2.0m)(6.6m)230.0k

Net Change in Cash

3.4m(3.8m)217.0k835.0k1.8m4.5m14.3m

Interest Paid

28.0k19.0k8.0k13.0k575.0k

Income Taxes Paid

1.0k123.0k285.0k

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

(817.0k)(1.8m)(3.3m)(1.4m)(2.7m)(4.3m)(1.0m)(2.0m)(2.3m)(871.0k)(1.7m)(1.8m)706.0k2.2m3.6m1.9m4.5m12.3m2.7m3.7m8.6m4.9m

Depreciation and Amortization

47.0k92.0k140.0k59.0k129.0k211.0k110.0k221.0k336.0k267.0k409.0k121.0k249.0k373.0k177.0k307.0k579.0k190.0k235.0k412.0k155.0k

Accounts Receivable

(21.0k)13.0k(186.0k)(52.0k)20.0k(203.0k)685.0k653.0k315.0k(13.0k)(607.0k)(1.1m)(535.0k)(1.2m)268.0k(730.0k)(512.0k)1.9m2.5m(13.0k)(1.6m)

Inventories

(299.0k)

Accounts Payable

(116.0k)(95.0k)(39.0k)27.0k(28.0k)(449.0k)(409.0k)(558.0k)310.0k96.0k197.0k(147.0k)(303.0k)(237.0k)(23.0k)125.0k389.0k39.0k(131.0k)(2.0k)(207.0k)

Cash From Operating Activities

(1.0m)(1.9m)(2.3m)(1.5m)(2.4m)(2.5m)(1.1m)(1.5m)(1.9m)(70.0k)181.0k(366.0k)1.5m2.7m1.7m4.4m9.1m3.7m6.1m9.6m4.6m

Purchases of PP&E

(4.0k)(6.0k)(5.0k)(19.0k)(45.0k)(195.0k)(6.0k)(15.0k)(140.0k)(12.0k)(24.0k)(34.0k)(105.0k)(131.0k)(31.0k)(63.0k)(106.0k)(91.0k)(100.0k)(103.0k)(133.0k)

Cash From Investing Activities

(120.0k)(284.0k)(396.0k)(90.0k)(306.0k)1.4m(71.0k)(321.0k)(555.0k)(603.0k)(786.0k)(92.0k)(243.0k)(453.0k)(456.0k)(842.0k)(1.2m)(272.0k)(247.0k)(722.0k)(216.0k)

Long-term Borrowings

(27.0k)(53.0k)(156.0k)(2.0m)(17.0k)(69.0k)(106.0k)(739.0k)(1.0m)(1.1m)

Cash From Financing Activities

8.0m8.0m7.9m498.0k912.0k(1.2m)2.2m2.5m2.6m547.0k561.0k(580.0k)(713.0k)(568.0k)13.0k(2.6m)(2.6m)3.0k70.0k174.0k9.0k

Net Change in Cash

6.9m5.8m5.2m(1.1m)(1.8m)(2.2m)1.0m617.0k112.0k(126.0k)(44.0k)(1.0m)552.0k1.6m1.3m898.0k5.3m3.5m5.9m9.1m4.4m

Interest Paid

4.0k9.0k23.0k8.0k13.0k19.0k3.0k7.0k10.0k142.0k191.0k192.0k

Semler Scientific Ratios

USDQ1, 2014

Financial Leverage

1.3 x

Semler Scientific Employee Rating

4.18 votes
Culture & Values
3.7
Work/Life Balance
3.7
Senior Management
4
Salary & Benefits
4.1
Career Opportunities
4
Source